Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Global Antiplatelet Market: Analysis By Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other Drug Classes), By Route of Administration (Oral and Injectable), By Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count 146 Units Referenced US ... Read More
-
Patient Monitoring Devices
... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More
-
Embolotherapy
... of 7.5% over the analysis period 2023-2030. Embolic Agents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$6.7 Billion by the end of the analysis period. ... Read More
-
2024 France Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United Kingdom Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 China Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 India Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Japan Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 North America Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Asia-Pacific Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Europe Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Latin America Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Germany Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Global Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Global Myocardial Infarction (MI) Therapeutics Market 2024-2028
... the myocardial infarction (Mi) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Cardiovascular and Soft Tissue Repair Patches
... the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. ePTFE Raw Material, one of the segments analyzed in the report, is expected ... Read More
-
Cardiovascular Repair and Reconstruction Devices
... is expected to reach US$6.2 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Cardiovascular Grafts, one of the segments analyzed in the report, is expected to record a 5.4% ... Read More
-
Acute Ischemic Stroke Diagnosis and Treatment
... the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Computed Tomography, one of the segments analyzed in the report, is expected to ... Read More
-
Angiography Devices
... at a CAGR of 3.8% over the analysis period 2023-2030. Angiography Systems, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.8 Billion by the end of ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices
... reach US$37.9 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Heart Valve Repair and Replacement Devices
... the year 2023, is expected to reach US$43.1 Billion by 2030, growing at a CAGR of 16.0% over the analysis period 2023-2030. Replacement Devices Application, one of the segments analyzed in the report, is expected ... Read More
-
Statins
... of 1.8% over the analysis period 2023-2030. Synthetic Statins, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$12.2 Billion by the end of the analysis period. ... Read More
-
Heart Failure Drugs
... by 2030, growing at a CAGR of 12.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 16.2% CAGR The Heart Failure Drugs market ... Read More
-
Cardiologists
... practices, health care organizations, and hospitals, as well as academic, government, or research institutions. Leading institutions for cardiology and heart surgery include The Cleveland Clinic and the Mayo Clinic (both based in the US), along ... Read More